Impact of Personalized Dosing of Faricimab on Treatment Outcomes in nAMD


Dr Varun Chaudhary discusses the impact of personalized treat-and-extend-based dosing on visual and anatomic outcomes of faricimab in the TENAYA and LUCERNE clinical trials in neovascular AMD.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.